Kitov Pharmaceuticals Holdings Ltd. (KTOV)
(Delayed Data from NSDQ)
$1.07 USD
+0.04 (3.88%)
Updated May 3, 2019 04:00 PM ET
After-Market: $1.06 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.07 USD
+0.04 (3.88%)
Updated May 3, 2019 04:00 PM ET
After-Market: $1.06 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Is Kitov Pharmaceuticals Holdings (KTOV) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (KTOV) Outperforming Other Medical Stocks This Year?
Is Kitov Pharmaceuticals Holdings (KTOV) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (KTOV) Outperforming Other Medical Stocks This Year?
Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY
by Zacks Equity Research
Pfizer's (PFE) tafamidis application gets FDA's priority review. Regulatory updates for Roche's (RHHBY) and Bristol-Myers'(BMY) cancer combination drugs in focus.
Kitov Pharma's Stock Up on Anti-Cancer Candidate Findings
by Zacks Equity Research
Shares of Kitov Pharma (KTOV) soar about 169% as the company's anti-cancer candidate, NT219 shows positive results.
Kitov (KTOV) Gets Approval from FDA for Consensi, Shares Up
by Zacks Equity Research
Kitov Pharma (KTOV) gained as the FDA approved Consensi (amlodipine and celecoxib) oral tablets for the treatment of osteoarthritis pain and hypertension.